Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

STOLL, DAVID

NPI: 1114927431 · WOONSOCKET, RI 02895 · Hematology & Oncology Physician · NPI assigned 07/28/2005

$1.42M
Total Medicaid Paid
12,525
Total Claims
9,910
Beneficiaries
8
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,366 $260K
2019 1,754 $375K
2020 2,274 $386K
2021 2,019 $213K
2022 1,825 $84K
2023 1,268 $57K
2024 1,019 $45K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,247 1,863 $1.02M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 5,767 5,122 $356K
80305 3,284 2,757 $27K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 114 72 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 66 57 $4K
99205 Prolong outpt/office vis 19 13 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 15 14 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 13 12 $430.34